A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2-D liquid separations, protein microarrays, and tandem mass spectrometry

Proteomics - Clinical Applications

Volumn 3, Issue 1, 2009, Pages 51-66

  Patwa, Tasneem H ^a   Wang, Yanfei ^a   Miller, Fred R ^b   Goodison, Steve ^c   Pennathur, Subramaniam ^d   Barder, Timothy J ^e   Lubman, David M ^a,f  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e Eprogen Inc   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Breast cancer; Liquid chromatography; Phosphorylation; Protein microarray; Tandem mass spectrometry

Indexed keywords

ARGININE; CYTOCHROME P450; CYTOKERATIN 16; CYTOKERATIN 8; HISTONE ACETYLTRANSFERASE; HISTONE H1; HISTONE H2A; LAMIN A; LAMIN B; LAMIN C; LIPOCORTIN 2; NEUROBLAST DIFFERENTIATION ASSOCIATED PROTEIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN ACINUS; PROTEIN BAD; PROTEIN BAX; PROTEIN P130; REGULATOR PROTEIN; RIBOSOMAL PROTEIN L14; RIBOSOMAL PROTEIN L24; RIBOSOMAL PROTEIN L34; RIBOSOMAL PROTEIN L36; RIBOSOME PROTEIN; SCAFFOLD ATTACHMENT FACTOR B; SERINE; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIMENTIN; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; PRECANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; SEPARATION TECHNIQUE; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 65549128783     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800097     Document Type: Article

References (42)

1. American Cancer Society. Breast Cancer Facts and Figures 2007-2008. Atlanta: American Cancer Society, Inc.
2. Wolf-Yadlin, A., Kumar, N., Zhang, Y., Hautaniemi, S. et al., Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol. Syst. Biol. 2006, 2, 54.
3. Yu, Y., Hao, Y., Feig, L. A., The R-Ras GTPase mediates cross talk between estrogen and insulin signaling in breast cancer cells. Mol. Cell. Biol. 2006, 26, 6372-6380.
4. Hunter, T., The role of tyrosine phosphorylation in cell growth and disease. Harvey Lect. 1998, 94, 81-119.
5. Chow, S., Minden, M. D., Hedley, D. W., Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients. Exp. Hematol. 2006, 34, 1183-1191.
6. Spickett, C. M., Pitt, A. R., Morrice, N., Kolch, W., Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction. Biochim. Biophys. Acta 2006, 1764, 1823-1841.
7. Cohen, P., The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur. J. Biochem. 2001, 268, 5001-5010.
8. Perkins, N. D., Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006, 25, 6717-6730.
9. Krueger, K. E., Srivastava, S., Posttranslational protein modifications: Current implications for cancer detection, prevention, and therapeutics. Mol. Cell. Proteomics 2006, 5, 1799-1810.
10. Morandell, S., Stasyk, T., Grosstessner-Hain, K., Roitinger, E. et al., Phosphoproteomics strategies for the functional analysis of signal transduction. Proteomics 2006, 6, 4047-4056.
11. Yu, L. R., Issaq, H. J., Veenstra, T. D., Phosphoproteornics for the discovery of kinases as cancer biornarkers and drug targets. Proteomics Clin. Appl. 2007, 1, 1042-1057.
12. Tavares, A., Cimarosti, H., Valentim, L., Salbego, C., Profile of phosphoprotein labelling in organotypic slice cultures of rat hippocampus. Neuroreport 2001, 12, 2705-2709.
13. Kaufmann, H., Bailey, J. E., Fussenegger, M., Use of antibodies for detection of phosphorylated proteins separated by two-dimensional gel electrophoresis. Proteomics 2001, 1, 194-199.
14. Goodman, T., Schulenberg, B., Steinberg, T. H., Patton, W. F., Detection of phosphoproteins on electroblot membranes using a small-molecule organic fluorophore. Electrophoresis 2004, 25, 2533-2538.
15. Martin, K., Steinberg, T. H., Goodman, T., Schulenberg, B. et al., Strategies and solid-phase formats for the analysis of protein and peptide phosphorylation employing a novel fluorescent phosphorylation sensor dye. Comb. Chem. High Throughput Screen. 2003, 6, 331-339.
16. Steinberg, T. H., Agnew, B. J., Gee, K. R., Leung, W. Y. et al., Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 2003, 3, 1128-1144.
17. Martin, K., Steinberg, T. H., Cooley, L. A., Gee, K. R. et al., Quantitative analysis of protein phosphorylation status and protein kinase activity on microarrays using a novel fluorescent phosphorylation sensor dye. Proteomics 2003, 3, 1244-1255.
18. McDonald, T., Sheng, S., Stanley, B., Chen, D. et al., Expanding the subproteome of the inner mitochondria using protein separation technologies: One- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol. Cell. Proteomics 2006, 5, 2392-2411.
19. Sheng, S., Chen, D., Van Eyk, J. E., Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: Optimization and protein database. Mol. Cell. Proteomics 2006, 5, 26-34.
20. Billecke, C., Malik, I., Movsisyan, A., Sulghani, S. et al., Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles. Mol. Cell. Proteomics 2006, 5, 35-42.
21. Skalnikova, H., Halada, P., Dzubak, P., Hajduch, M., Kovarova, H., Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: Identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry. Technol. Cancer Res. Treat. 2005, 4, 447-454.
22. Cantin, G. T., Yates, J. R., III, Strategies for shotgun identification of post-translational modifications by mass spectrometry. J. Chromatogr. A 2004, 1053, 7-14.
23. Cantin, G. T., Venable, J. D., Cociorva, D., Yates, J. R., III, Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway. J. Proteome Res. 2006, 5, 127-134.
24. MacCoss, M. J., McDonald, W. H., Saraf, A., Sadygov, R. et al., Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA 2002, 99, 7900-7905.
25. Andersson, L., Porath, J., Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal. Biochem. 1986, 154, 250-254.
26. Ndassa, Y. M., Orsi, C., Marto, J. A., Chen, S., Ross, M. M., Improved immobilized metal affinity chromatography for large-scale phosphoproteomics applications. J. Proteome Res. 2006, 5, 2789-2799.
27. Kweon, H. K., Hakansson, K., Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis. Anal. Chem. 2006, 78, 1743-1749.
28. Nesvizhskii, A. I., Protein identification by tandem mass spectrometry and sequence database searching. Methods Mol. Biol. 2007, 367, 87-119.
29. Schabacker, D. S., Stefanovska, I., Gavin, I., Pedrak, C., Chandler, D. P., Protein array staining methods for undefined protein content, manufacturing quality control, and performance validation. Anal. Biochem. 2006, 359, 84-93.
30. Pal, M., Moffa, A., Sreekumar, A., Ethier, S. P. et al., Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal. Chem. 2006, 78, 702-710.
31. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H., Miller, F. R., MCF10AT: A model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 1996, 148, 313-319.
32. Miller, F. R., Xenograft models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia 2000, 5, 379-391.
33. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D. et al., Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 2001, 65, 101-110.
34. Stasyk, T., Morandell, S., Bakry, R., Feuerstein, I. et al., Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining. Electrophoresis 2005, 26, 2850-2854.
35. Godovac-Zimmermann, J., Soskic, V., Poznanovic, S., Brianza, F., Functional proteomics of signal transduction by membrane receptors. Electrophoresis 1999, 20, 952-961.
36. Zhu, K., Zhao, J., Lubman, D. M., Miller, F. R., Barder, T. J., Protein p/shifts due to posttranslational modifications in the separation and characterization of proteins. Anal. Chem. 2005, 77, 2745-2755.
37. Datta, S. R., Ranger, A. M., Lin, M. Z., Sturgill, J. F. et al., Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 2002, 3, 631-643.
38. Sastry, K. S., Smith, A. J., Karpova, Y., Datta, S. R., Kulik, G., Diverse antiapoptotic signaling pathways activated by vasoactive intestinal polypeptide, epidermal growth factor, and phosphatidylinositol 3-kinase in prostate cancer cells converge on BAD. J. Biol. Chem. 2006, 281, 20891-20901.
39. Xin, M., Deng, X., Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J. Biol. Chem. 2005, 280, 10781-10789.
40. Kim, B. J., Ryu, S. W., Song, B. J., JNK-and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 2006, 281, 21256-21265.
41. Hu, Y., Yao, J., Liu, Z., Liu, X. et al., Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation. EMBO J. 2005, 24, 3543-3554.
42. Balthazart, J., Baillien, M., Ball, G. F., Phosphorylation processes mediate rapid changes of brain aromatase activity. J. Steroid Biochem. Mol. Biol. 2001, 79, 261-277.